Jefferies Financial Group’s Novo Nordisk NVO Stock Holding History

Jefferies Financial Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-80,000	Closed	-$4.07M	–	2073
2025 Q4	$4.07M	Buy	+80,000	New	+$4.09M	0.02%	548
2025 Q3	–	Sell	-10,000	Closed	-$690K	–	1612
2025 Q2	$690K	Buy	+10,000	New	+$680K	0.01%	823
2025 Q1	–	Sell	-83,300	Closed	-$7.17M	–	1886
2024 Q4	$7.17M	Buy	83,300 +80,000	+2,424%	+$8.65M	0.04%	279
2024 Q3	$393K	Buy	+3,300	New	+$440K	﹤0.01%	1045
2024 Q1	–	Sell	-141,600	Closed	-$14.6M	–	1894
2023 Q4	$14.6M	Buy	+141,600	New	+$14M	0.1%	153

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Jefferies Financial Group's NVO Position: Q1 2026 in Review

Jefferies Financial Group increased its Novo Nordisk (NVO) stake by 682% in Q1 2026, buying an estimated $683K and bringing the position to 16,524 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Jefferies Financial Group first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.29M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Jefferies Financial Group held 16,524 shares of Novo Nordisk worth $607K as of Q1 2026.
Jefferies Financial Group bought 14,412 Novo Nordisk shares in Q1 2026, an estimated $683K.
Novo Nordisk made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1127 holding.
Jefferies Financial Group first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
Jefferies Financial Group's Novo Nordisk position peaked at $2.29M in Q3 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.